Board Meeting2 Nov 2026, 04:28 pm
Blueblood Ventures Board Meeting on Nov 13, 2026
AI Summary
Blueblood Ventures Ltd has announced that its Board of Directors will convene on November 13, 2026, to consider and approve the Unaudited Standalone Financial Results for the second quarter and half-year ended September 30, 2026. Additionally, the company confirmed the trading window for designated persons, which closed on September 30, 2026, will reopen on November 15, 2026.
Key Highlights
- Board meeting scheduled for November 13, 2026.
- To approve Unaudited Standalone Financial Results for Q2 and H1 FY27.
- Trading window to reopen on November 15, 2026.
- Insider trading regulations compliance noted.
Price Impact
More from BVL